Cannabis Law Report

JANUARY 20, 2022

Q4 2021 Bookings $150 Million Greater Than Prior Guidance of $100 Million. The more than $250 million in new bookings for the fourth quarter of 2021 is $150 million greater than the previously provided fourth quarter guidance of $100 million and over $220 million greater than the bookings the Company generated in the third quarter of 2021.

Extraction 52

Extraction Cultivation Hemp Data 52

Cannabis Law Report

OCTOBER 29, 2021

. (“ SOL Global ” or the “ Company “) (CSE: SOL) (OTCPK: SOLCF) (Frankfurt: 9SB) is pleased to present its investors with select unaudited financial results and highlights for the three and nine-month period ended August 31, 2021. For the three-months ended August 31, 2021, the Company recorded a loss of $(62.4)

Events 52

Events Business Media Conditions 52

Cannabis Law Report

DECEMBER 3, 2021

We are honored to be at the AES Meeting this year after almost a year of planning from our medical and scientific affairs, clinical, and advocacy teams, with nine presentations spanning our IV and oral portfolio—Marinus’ largest data showing to date,” said Scott Braunstein, M.D., Chief Executive Officer of Marinus Pharmaceuticals. “We

Epilepsy 52

Epilepsy Pharmaceutical Data Clinical Trials 52

Cannabis Law Report

JUNE 23, 2021

TORONTO, June 23, 2021 (GLOBE NEWSWIRE) — RYAH Group, Inc. RYAH is pleased to contribute RYAH’s IoT devices and data platform and work with Medicann toward perfecting prescribing practices and dosing regimens,” said Gregory Wagner , CEO of RYAH Group, Inc. About RYAH Group, Inc. RYAH Group, Inc. Forward-Looking Statements.

Programs 100

Programs Data Events Collective 100

Cannabis Law Report

JUNE 1, 2021

TORONTO, June 01, 2021 (GLOBE NEWSWIRE) — via InvestorWire – RYAH Group, Inc. We are pleased to bring RYAH’s IoT device and integrated data solutions to the United Kingdom, providing a new level of session accuracy, patient feedback consistency, and data integrity to the clinical framework in plant-based medicine research.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

JULY 19, 2021

July 19, 2021 07:58 ET | Source: Potbotics, Inc. Toronto, July 19, 2021 (GLOBE NEWSWIRE) — via InvestorWire — RYAH Group, Inc. This is a precedent-setting experiment that is expected to generate the data needed to facilitate an accurate milligram dosing experience with dry herb.”. billion by 2027.

Therapy 76

Therapy Data Research and Development Events 76

Cannabis Law Report

SEPTEMBER 22, 2021

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose. New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Watch how Supera-CBD works. “We

Pharmaceutical 52

Pharmaceutical Data CBD Clinical Trials 52

Cannabis Law Report

JANUARY 4, 2022

Assay”) as a Laboratory Developed Test (LDT), pending a final review of the assay’s validation data by NYSDOH. With the conditional approval, ADCL can immediately employ the Linea 2.0 With the conditional approval, ADCL can immediately employ the Linea 2.0 Assay (the “Linea 2.0 The Linea 2.0 The performance of the Linea 2.0

Conditions 52

Conditions Research and Development Therapy Supply Chain 52

Cannabis Law Report

NOVEMBER 26, 2021

(NYSE American: CANF) (TASE: CFBI), a biotechnology company advancing a pipeline of proprietary small molecule drugs that address inflammatory, cancer and liver diseases, today announced financial results for the quarter ended September 30, 2021. On September 30, 2021, Can-Fite had approximately $13.3 Fortified Balance Sheet.

Clinical Trials 52

Clinical Trials Research and Development Treatment Data 52

Cannabis Law Report

OCTOBER 27, 2021

2021 Outlook Adjusted for Amplified Inflation and Supply Chain Challenges. Nasdaq: ROCK), a leading manufacturer and provider of products and services for the renewable energy, residential, agtech and infrastructure markets, today reported its financial results for the three-month period ended September 30, 2021. BUFFALO, N.Y.–(BUSINESS

Supply Chain 52

Supply Chain Business Environment Data 52

Cannabis Law Report

SEPTEMBER 29, 2021

(NASDAQ and CSE: WTER) (the “Company”), the country’s largest independent alkaline company and The Clean Beverage Company™, today shared highlights from the most recent Nielsen data for the 52-week and 4-week periods ending September 11, 2021. The Company’s unit growth in Grocery outpaces the entire category by 12.6x

Data 52

Data Retail Supply Chain Food 52

Cannabis Law Report

OCTOBER 24, 2021

We could speak forever just about the cannabis industry and the road to 2021, but as forensic accountants who specialize in economic damage quantification, the subject of this article is around lost profits exposure in the cannabis industry. At least until there is more historical data and the market landscape normalizes (whatever normal is).

Strains 52

Strains Edibles Extraction Vaping 52

Cannabis Law Report

JULY 29, 2021

OTTAWA, ON , July 29, 2021 /PRNewswire/ – Tetra Bio-Pharma Inc (“Tetra” or the Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA: JAM1), a leader in cannabinoid-based drug discovery and development has announced that it filed a PCT patent application for Cannabis Plant Residue and Use Thereof, PCT Patent Application No.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

Illinois News Joint

JANUARY 5, 2023

are the most since legalization in Illinois and a 12% increase from 2021 totals of $1,379,088,278.61 and 20% from 2021 totals of $669,084,410.12. For 2022, Illinois sold a total of 36,435,129 cannabis items, an increase of 20% from 2021. Recreational cannabis sales for 2021 totals included: January: $88,813,872.78.

Dispensary 73

Dispensary Recreational Cannabis Collective 73

Cannabis Law Report

JULY 19, 2021

TORONTO , July 19, 2021 /CNW/ – Halo Collective Inc. (“Halo” or the “Company”) (NEO: HALO) (OTCQX: HCANF) (Germany: A9KN), a vertically integrated cannabis company, announced today that it has entered into a brand licensing arrangement (the “Licensing Agreement”) with Brezwald Corp.

Collective 105

Collective Data Cultivation Events 105

Cannabis Law Report

JULY 6, 2021

High Tide gains access to Daily High Club’s over 15,000 subscription box members who are ideal customers for High Tide to potentially launch cannabis subscription boxes in the event of U.S. million in EBITDA during the 12 months ended April 2021. – July 6, 2021 (CNW Group/High Tide Inc.). federal legalization.

Consumption 116

Consumption Retail Events Media 116

Cannabis Law Report

SEPTEMBER 29, 2021

(CSE: CANN) (OTCQX: HERTF) ( “Heritage ” or the “Company ”), today announced its financial results as at and for the three- and nine-month periods ended July 31, 2021 (“ Q3 2021 ”). Key Financial Highlights of Fiscal Q3 2021. million in the third quarter of 2021, an increase of $2.7 Gross profit in Q3 2021 was $1.2

Concentrates 52

Concentrates Events Cannabis Vaping 52

Cannabis Law Report

JUNE 2, 2021

EDMONTON, AB , June 2, 2021 /CNW/ – Nova Cannabis Inc. Growth in Ontario : On Track to open at least 30 Value Buds stores in 2021. million in Shares, based on the 10-day volume weighted average price (VWAP) of the Shares on June 1, 2021. .” million in cash and $1.1 million in cash and $1.1

Business 105

Business Hybrid Retail Conditions 105

Cannabis Law Report

NOVEMBER 12, 2021

Revises 2021 Guidance to $470M – $485M Revenue, $85M – $95M Adjusted EBITDA and 46% Adjusted Gross Margin for Full Year 2021. NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE: 3LP) (“Columbia Care” or the “Company”) today reported financial and operating results for the third quarter ended September 30, 2021. (NEO:

Dispensary 52

Dispensary Seed-To-Sale Cultivation Research and Development 52

Canna Law Blog

MARCH 30, 2022

Data reveal a concerning increase in violent crime in many U.S. cities during COVID in 2020 and 2021. This includes both steps to prevent or mitigate the risks of criminal acts as well as protections in the event that a crime does occur. The reason that cannabis businesses are being hit particularly hard is not hard to fathom.

Business 82

Business Policy Events Conditions 82

Cannabis Law Report

AUGUST 14, 2021

– August 12, 2021) – Mary Agrotechnologies Inc. This partnership marks Mary AG’s first application of farm-level technology, taking its knowledge in automated systems and applying that expertise to a holistic, controlled growing condition that incorporates automated plant health assessment. CSE: MARY).

Hemp 105

Hemp Supply Chain Cannabinoids Extraction 105

Cannabis Law Report

DECEMBER 9, 2021

“Partnering with Fyllo reinforces our commitment to delivering innovative data solutions designed to enhance our clients’ audience reach strategies,” said Jay Baum , Chief Commercial Officer at Tremor Video. Learn more about Tremor Video’s data-driven audience solutions at www.tremorvideo.com. Traditional segments (e.g.

CBD 52

CBD Data Compliance Compliance 52

Cannabis Law Report

JUNE 16, 2021

Genetic Screening Platform Technology and Data to Strengthen Entheon’s Psychedelic-Assisted Protocols. – June 16, 2021) – Entheon Biomedical Corp. Developing insights through genetic testing and data are a key part of that mission.” Vancouver, British Columbia–(Newsfile Corp.

Research and Development 105

Research and Development Data Conditions Events 105

Cannabis Law Report

NOVEMBER 5, 2021

Third Quarter 2021 Revenue. ($ in 000s). 9/30/2021. 6/30/2021. $. %. Third Quarter 2021 Operating Results. . 9/30/2021. 6/30/2021. $. %. . Compared with the second quarter of 2021, selling expense was up $236,000, or 9%, to $2.8 June 30, 2021. Three Months Ended. 9/30/2020. $. %. Net Revenue.

Business 52

Business Data Conditions Events 52

Cannabis Law Report

JUNE 16, 2021

This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol. Training will be provided within the research program for licensed practitioners to assess the safety of psychedelic medicines and to classify and report positive and adverse events.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

JUNE 1, 2021

Canopy Growth Reports Fourth Quarter and Fiscal Year 2021 Financial Results. Achieves 37% revenue growth in FY 2021 with strong double-digit growth across both cannabis and other consumer products businesses. Fourth Quarter Fiscal 2021 Financial Summary. (in Fiscal Year 2021 Financial Summary. (in Net revenue. 2,800) bps.

Data 95

Data Vaping Supply Chain Business 95

The Cannigma

MARCH 25, 2021

It is also crucial so that the correct data is collected in order to inform further research and clinical trials that are necessary for cannabis medicines to reach the UK National Health Service. Our next series of MDT webinars on cannabis for symptom management in oncology takes place on March 29, 2021.

Patients 145

Patients Clinical Trials Medicine Events 145

Cannabis Law Report

DECEMBER 7, 2021

Scientific Reports volume 11 , Article number: 23462 ( 2021 ) Cite this article. While cannabidiol was associated with a reduction in reported seizure events (RR?=?0.59, A qualitative assessment suggests that medical cannabinoids might be associated with adverse mental events. Stolar & Ilan Matok. Metrics details.

Safety 52

Safety Cannabinoids Events Data 52

Cannabis Law Report

AUGUST 6, 2021

Adjusted EBITDA loss in Q1 2022 was $64 million , a $29 million narrower loss versus Q1 2021 driven by higher sales and lower operating expenses. Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) today announces its financial results for the first quarter fiscal 2022 ended June 30, 2021.

Vaping 105

Vaping Research and Development Data Business 105

Cannabis Law Report

JUNE 9, 2021

(“Jushi” or the “Company”) (CSE: JUSH ) (OTCMKTS: JUSHF ), a vertically integrated, multi-state cannabis operator, provides a detailed operational update on the Company’s recent activities and progress, along with an overview of Jushi’s First Quarter 2021 Financial Results. First Quarter 2021 Highlights. March 31, 2021.

Retail 59

Retail Business Cultivation Events 59

Cannabis Law Report

SEPTEMBER 13, 2021

(Nasdaq: MYMD) (“MyMD” or “the Company”), a clinical stage pharmaceutical company committed to extending healthy lifespan, today announced that it intends to initiate dosing for a Phase 2 trial of MYMD-1’s function in delaying aging early in the fourth quarter of 2021. 3 Nature Aging | VOL 1 | July 2021 | p. Chief Scientific Officer.

Clinical Trials 52

Clinical Trials Pharmaceutical Research and Development Therapy 52

Cannabis Law Report

AUGUST 10, 2021

10, 2021 (GLOBE NEWSWIRE) — The Scotts Miracle-Gro Company (NYSE: SMG) announced today the creation of a newly formed subsidiary, The Hawthorne Collective, which will focus on strategic minority investments in areas of the cannabis industry not currently pursued by The Hawthorne Gardening Company. MARYSVILLE, Ohio, Aug.

Collective 105

Collective Hydroponic Events Business 105

Cannabis Law Report

JUNE 7, 2021

1.526 were reduced as expected and consistent with other CDC-reported data on vaccine-induced antibody neutralization against these variants 1. Department of Agriculture (USDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final or conditional approval from the U.S.

Clinical Trials 64

Clinical Trials Research and Development Therapy Supply Chain 64

Cannabis Law Report

JANUARY 5, 2022

Q4 2021 Revenue of $3.76M versus $3.03M in Q3 2021, an increase of 24%. Q4 2021 aEBITDA 1 margin of 30% ($1.14M), versus 25% ($0.77M) in Q3 2021, an increase of 48% ($0.37M). Fourth Quarter 2021 Financial Summary. Revenue of $3.76M compared to $3.03M in the Q3 2021, an increase of 24%. compared to 59.1%

Seed-To-Sale 52

Seed-To-Sale Business Packaging Law 52

Cannabis Law Report

OCTOBER 22, 2021

–The Company expects to hold a Research & Development event to review,these breakthrough findings in Q4 2021 that will be open to the public, shareholders, analysts and the media– TORONTO, CANADA – October 19, 2021 – Cybin Inc.

Research and Development 52

Research and Development Safety Media Data 52

Cannabis Law Report

NOVEMBER 16, 2021

House of Lithium made the Investment through the purchase of a convertible promissory note (the “ Convertible Note ”) issued by Reby on October 14, 2021. between 2021-2031. Previously (at age 18), Pep founded and was the Chairman and CEO of Fever ( www.feverup.com ), the world’s leading event discovery platform.

Data 52

Data Events Research and Development Business 52

Cannabis Law Report

AUGUST 17, 2021

Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. We believe the totality of the data is encouraging and supports advancing to Phase 3. Data Highlights. Food and Drug Administration (FDA) has granted orphan drug designation to ganaxolone in TSC. RADNOR, Pa.–(BUSINESS

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98